NCT05530785 2022-09-07
Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT
Hunan Province Tumor Hospital
Phase NA Unknown
Clinical Trials
5 trialsNCT05339581 2022-04-27
iPLENTY-pvtt
RenJi Hospital
Phase NA Unknown
NCT05233358 2022-02-10
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure
The Central Hospital of Lishui City
Phase NA Unknown
NCT04728568 2021-08-10
Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma
Beijing Tiantan Hospital
Phase NA Unknown
NCT04813406 2021-03-24
Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
Henan Provincial People's Hospital
Phase NA Unknown